Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
CNBC
Tue, 05/21/24 - 07:11 pm
Tags:
Eli Lilly, Novo Nordisk, insulin, diabetes
Eli Lilly pays Aktis $60M upfront to further dial into radiopharma signal
Fierce Biotech
Tue, 05/21/24 - 11:13 am
Tags:
Eli Lilly, Aktis Oncolgy, radiopharmaceuticals
In Big Pharma's growth rankings, Lilly took top spot from Novo Nordisk in Q1
Fierce Pharma
Thu, 05/16/24 - 09:51 pm
Tags:
Big Pharma, Eli Lilly, Novo Nordisk, earnings, Amgen
Lilly keeps on Novo's tail by reporting weekly insulin hits primary endpoint in 2 pivotal trials
Fierce Biotech
Thu, 05/16/24 - 11:27 am
Tags:
Eli Lilly, Novo Nordisk, insulin, weekly insulin
Eli Lilly expands U.S. Olympic team sponsorship ahead of 2024 Paris games
Medical Marketing and Media
Wed, 05/15/24 - 10:55 pm
Tags:
Eli Lilly, Olympics, sponsorship, pharma marketing
As Lilly surges, headwinds against its weight loss drugs are growing
Pharma Voice
Wed, 05/15/24 - 11:18 am
Tags:
Eli Lilly, Mounjaro, drug pricing, earnings
Big Pharma’s most improved drugs: a new generation of blockbusters
Pharma Voice
Tue, 05/14/24 - 11:34 am
Tags:
Big Pharma, Eli Lilly, Mounjaro, Novo Nordisk, Wegovy, JNJ, Tecvayli, Merck, Vaxneuvance, AbbVie, Qulipta, AstraZeneca, Saphnelo, Novartis, Leqvio, Roche, Genentech, Vabysmo, Amgen, Evenity, Pfizer, Vyndaqel
Lilly's next-gen obesity drug brings Innovent a phase 3 win in diabetes
Fierce Biotech
Thu, 05/9/24 - 11:48 am
Tags:
Innovent, Eli Lilly, mazdutide, obesity, type 2 diabetes
Lilly gets a date with FDA to discuss Alzheimer's med donanemab
Fierce Biotech
Tue, 05/7/24 - 11:21 am
Tags:
Eli Lilly, FDA, advisory committees, Alzheimer's disease, donanemab
Eli Lilly Gears Up for Donanemab Adcomm as FDA Ponders Changes to Format
BioSpace
Mon, 05/6/24 - 11:43 am
Tags:
Eli Lilly, FDA, donanemab, advisory committees, Alzheimer's disease
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
Motley Fool
Sun, 05/5/24 - 11:40 pm
Tags:
Prizer, danuglipron, obesity, Eli Lilly, Novo Nordisk
Regeneron, Lilly grapple with clinical endpoints as obesity space moves to improving weight loss
Fierce Biotech
Thu, 05/2/24 - 10:14 pm
Tags:
Regeneron, Eli Lilly, Zepbound, obesity, trevogrumab, bimagrumab
How Lilly is using its Mounjaro millions to position as biotechs’ ‘partner of choice’
Fierce Biotech
Wed, 05/1/24 - 10:55 am
Tags:
Eli Lilly, Gateway Labs, incubators, Mounjaro, biotech
Eli Lilly’s growth drivers, Verzenio and Jardiance, suffer clinical setbacks
Fierce Pharma
Tue, 04/30/24 - 11:20 am
Tags:
Eli Lilly, Jardiance, Verzenio, clinical trials
How expanded use of GLP-1s could affect long-term outlooks for Eli Lilly and Novo Nordisk
Yahoo Finance
Tue, 04/30/24 - 08:56 am
Tags:
Novo Nordisk, Eli Lilly, earnings, obesity, weight loss, GLP-1 agonist, Ozempic, Wegovy, Zepbound, Mounjaro
Eli Lilly lifts sales view by $2 billion on soaring weight-loss drug demand
Reuters
Tue, 04/30/24 - 08:33 am
Tags:
Eli Lilly, earnings
Investigator-led trial of Lilly’s merestinib in solid tumours terminated
Clinical Trials Arena
Mon, 04/29/24 - 11:24 am
Tags:
Eli Lilly, merestinib, clinical trials, solid tumors
Why the obesity drug market is about to get a lot more crowded
Medical Marketing and Media
Fri, 04/26/24 - 11:49 am
Tags:
obesity, Novo Nordisk, Wegovy, Eli Lilly, Zepbound, Roche, AstraZeneca
As Lilly and BMS invest in manufacturing, demand for drugs still outweighs supply
Pharma Voice
Fri, 04/26/24 - 11:47 am
Tags:
drug shortages, drug manufacturing, Eli Lilly, Bristol Myers Squibb
Endeavor pulls in $132M to back cancer, lung disease drugs
BioPharma Dive
Wed, 04/24/24 - 08:45 am
Tags:
Endeavor BioMedicines, funding, IPF, Eli Lilly

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.